1-14 of 14
Martin Stork
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Teclistamab in Relapsed and Refractory Multiple Myeloma Patients - Czech Multi-Center Real World Evidence Analysis

Martin Stork, Jakub Radocha, Tomas Jelinek, Ivan Spicka, Tomas Pika, Alexandra Jungova, Jan Straub, Jiri Minarik, Ivanna Boichuk, Dominik Fric, Denisa Novakova, Tereza Popkova, Lenka Polcerova, Vladimir Maisnar, Ludek Pour, Roman Hajek
Journal: Blood
Blood (2024) 144 (Supplement 1): 5156.
https://doi.org/10.1182/blood-2024-202002
Published: 2024
Journal Articles

A Multicenter Phase 2 Study Evaluating the Optimized Schedule of Belantamab Mafodotin 1.9 Mg/Kg Q8W Plus Bortezomib and Dexamethasone in Relapsed Refractory Multiple Myeloma

Tereza Popkova, Jakub Radocha, Martin Stork, Jiří Minařík, Jan Straub, Alexandra Jungova, Petr Pavlicek, Tomas Jelinek, Vladimir Maisnar, Ludek Pour, Tomas Pika, František Sedlák, Jan Soukup, Hana Plonkova, Ludmila Muronova, Viera Sandecka, Petra Krhovska, David Zihala, Roman Hajek
Journal: Blood
Blood (2024) 144 (Supplement 1): 1999.
https://doi.org/10.1182/blood-2024-211224
Published: 2024
Journal Articles

Comparison of Lenalidomide Based Triplets (IRD, KRD and DRD) in Relapsed and Refractory Multiple Myeloma in Routine Practice

Jiri Minarik, Ludek Pour, Tomas Jelinek, Ivan Spicka, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Tomas Pika, Martin Stork, Jan Straub, Vladimir Maisnar, Roman Hajek
Journal: Blood
Blood (2023) 142 (Supplement 1): 4733.
https://doi.org/10.1182/blood-2023-179299
Published: 2023
Journal Articles

Patient Characteristics and Survival Outcomes of Lenalidomide Exposed non- Refractory vs. Lenalidomide Refractory Multiple Myeloma Patients in the HONEUR Federated Data Network

Roman Hajek, Henrik Sliwka, Martin Stork, Ivan Spicka, Tomas Jelinek, Jakub Radocha, Alexandra Jungova, Jiri Minarik, Jan Soukup, Nolen Joy Perualila, Joris Diels, Michel van Speybroeck, Nichola Erler-Yates, João Mendes, Kai Strobel, Sébastien Wischlen, Maximilian Merz
Journal: Blood
Blood (2022) 140 (Supplement 1): 7200–7202.
https://doi.org/10.1182/blood-2022-159401
Published: 2022
Journal Articles

Circulating Plasma Cells Are the Most Powerful Prognostic Marker in Transplant Ineligible Multiple Myeloma with 2% As a New Cut-Off for Primary Plasma Cell Leukemia

Tomas Jelinek, Renata Bezděková, David Zihala, Tereza Sevcikova, Lenka Capkova, Petra Polackova, Martin Stork, Zdenka Knechtova, Ondrej Venglar, Artur Jurczyszyn, Jorge J. Castillo, Miroslav Penka, Jakub Radocha, Sabina Sevcikova, Ludek Pour, Lucie Rihova, Roman Hajek
Journal: Blood
Blood (2021) 138 (Supplement 1): 546.
https://doi.org/10.1182/blood-2021-151592
Published: 2021
Journal Articles

Follow-up Analysis of Ixazomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in Routine Clinical Practice

Jiri Minarik, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Tomas Pika, Ludek Pour, Petr Pavlicek, Lubica Harvanova, Lenka Capkova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Martin Mistrik, Jaroslav Bacovsky, Vladimir Maisnar, Roman Hajek
Journal: Blood
Blood (2021) 138 (Supplement 1): 2716.
https://doi.org/10.1182/blood-2021-148836
Published: 2021
Journal Articles

Overall Survival Benefit of Ixazomib, Lenalidomide and Dexamethasone (IRD) over Lenalidomide and Dexamethasone (RD) in RRMM Patients Treated in Routine Clinical Practice: Results from the Czech Registry of Monoclonal Gammopathies (RMG)

Jiri Minarik, MD PhD, Tomas Pika, MD PhD, Jakub Radocha, Alexandra Jungova, Jan Straub, MD, Tomas Jelinek, MD, Ludek Pour, MD, Petr Pavlicek, MD, Martin Mistrik, MD PhD, Lucie Brožová, MSc, Petra Krhovska, Katerina Machalkova, Pavel Jindra, MD PhD, Ivan Spicka, MD PhD Prof, Hana Plonkova, MD, Martin Stork, MD, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, MD, Lukáš Stejskal, MD, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, MD, Vladimir Maisnar, MD PhD MBA, Roman Hajek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3139.
https://doi.org/10.1182/blood-2019-128865
Published: 2019
Journal Articles

Tumor Specific cfDNA Predicts Treatment Response of Multiple Myeloma Patients

David Vrabel, MSc, Jana Gregorova, MSc., Lenka Sedlarikova, MSc, Martina Almasi, Ing.,PhD, Renata Bezděková, MSc., Martin Stork, MD, Marta Krejci, Prof, MD PhD, Zdenek Adam, Prof, MD CSc, Ludek Pour, MD, Roman Hajek, MD PhD, Sabina Sevcikova, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3188.
https://doi.org/10.1182/blood-2018-99-114793
Published: 2018
Journal Articles

Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma

Martin Stork, MD, Sabina Sevcikova, PhD, Marta Krejci, Prof, MD PhD, Zdenek Adam, Prof. MD, Viera Sandecka, MD PhD, Vladimir Maisnar, MD TMD, MBA, Jakub Radocha, MD, Ivan Spicka, MD PhD Prof, Jan Straub, MD, Jiri Minarik, MD PhD, Tomas Pika, MD PhD, Alexandra Jungova, Evzen Gregora, MD, Petr Pavlicek, MD, David Vrabel, MSc, Jiri Jarkovsky, PhD, Lucie Brozova, MSc, Tomas Jelinek, MD, Roman Hajek, MD PhD, Ludek Pour, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5596.
https://doi.org/10.1182/blood-2018-99-114854
Published: 2018
Journal Articles

Treatment Outcomes of Real Life Elderly Multiple Myeloma Patients:Â Analysis from Registry of Monoclonal Gammopathies (RMG)

Jakub Radocha, MD, Roman Hajek, Lucie Brozova, MSc, Ludek Pour, MD, Ivan Spicka, MDPhDProf, Jiri Minarik, MD PhD, Evzen Gregora, MD, Alexandra Jungova, Jan Straub, MD, Tomas Jelinek, Tomas Pika, Petr Pavlicek, MD, Viera Sandecka, MDPhD, David Vrabel, MSc, Adriana Heindorfer, Martin Stork, MD, Michal Sykora, Vladimir Maisnar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2019.
https://doi.org/10.1182/blood-2018-99-111882
Published: 2018
Journal Articles

Treatment of Relapsed and Refractory Multiple Myeloma with Fully Oral Triplet IRD (ixazomib, lenalidomide and dexamethasone) Is Safe and with Significant Therapeutic Outcomes

Jiri Minarik, MD PhD, Petra Krhovska, Tomas Jelinek, Alexandra Jungova, Martin Mistrik, MD PhD, Tomas Pika, MD PhD, Evzen Gregora, MD, Vladimir Maisnar, MD, Jan Straub, MD, Ludek Pour, MD, Lucie Brozova, MSc, Jaroslav Bacovsky, Hana Plonkova, Pavel Jindra, MD PhD, Petr Pavlicek, MD, Jakub Radocha, MD, Ivan Spicka, MDPhDProf, Martin Stork, MD, Vlastimil Scudla, Prof, MD CSc, Roman Hajek
Journal: Blood
Blood (2018) 132 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2018-99-112046
Published: 2018
Journal Articles

Diagnostic Relevance of 18F-FDG PET/CT in Newly Diagnosed Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) : Single- Center Experience

Viera Sandecka, MD PhD, Ludek Pour, MD, Zdenek Adam, Prof, MD CSc, Martin Stork, MD, Marta Krejci, Prof, MD PhD, Jana Michalcova, MD, Zdenek Kral, MD CSc, Sabina Sevcikova, PhD, Zdeněk Řehák, MD PhD, Renata Koukalova, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1913.
https://doi.org/10.1182/blood-2018-99-111094
Published: 2018
Journal Articles

Bortezomib-Based Induction Treatment for Patients with Multiple Myeloma Ineligible for Autologous Stem Cell Transplantation: A Retrospective Multicenter Study in Czech Republic

Viera Sandecka, MD, Ludek Pour, Doc,MD PhD, Sabina Sevcikova, RNDr, PhD, Lucie Brozova, MSc, Jan Straub, MD, Vlastimil Scudla, Prof, MD CSc, Vladimir Maisnar, Prof, MD PhD, Petr Pavlicek, MD, Zdenek Adam, Prof, MD CSc, Marta Krejci, Prof, MD PhD, Martin Stork, MD, Tomas Jelinek, Hana Plonkova, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 5435.
https://doi.org/10.1182/blood.V130.Suppl_1.5435.5435
Published: 2017
Journal Articles

Whole Exome Sequencing of Plasma Cells Precancerosis MGUS and Malignant AL Amyloidosis Reveals Small Number of Shared Mutated Genes

Zuzana Kufova, Katerina Growkova, Petr Vojta, MSc, Jana Filipova, Michal Simicek, PhD, Tomas Jelinek, Martina Zatopkova, Sebastian Grosicki, MD PhD, Aneta Mikulasova, PhD, Marian Hajduch, MD PhD, Ludek Pour, Doc,MD PhD, Martin Stork, MD, Tereza Sevcikova, PhD, Roman Hajek
Journal: Blood
Blood (2017) 130 (Supplement 1): 4364.
https://doi.org/10.1182/blood.V130.Suppl_1.4364.4364
Published: 2017